-
1
-
-
0033836109
-
Can multidrug resistance mechanisms be modified?
-
Arceci RJ (2000) Can multidrug resistance mechanisms be modified? Br J Haematol 110:285
-
(2000)
Br J Haematol
, vol.110
, pp. 285
-
-
Arceci, R.J.1
-
2
-
-
0028199806
-
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance
-
Bartlett NL, Lum BL, Fisher GA, Brophy NA, Ehsan MN, Halsey J, Sikic BI (1994) Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance. J Clin Oncol 12:835
-
(1994)
J Clin Oncol
, vol.12
, pp. 835
-
-
Bartlett, N.L.1
Lum, B.L.2
Fisher, G.A.3
Brophy, N.A.4
Ehsan, M.N.5
Halsey, J.6
Sikic, B.I.7
-
3
-
-
0023919739
-
Effect of ketotifen on adriamycin toxicity: Role of histamine
-
Bartoli Klugman F, Decorti G, Candussio L, Mallardi F, Grill V, Zweyer M, Baldini L (1988) Effect of ketotifen on adriamycin toxicity: role of histamine. Cancer Lett 39:145
-
(1988)
Cancer Lett
, vol.39
, pp. 145
-
-
Bartoli Klugman, F.1
Decorti, G.2
Candussio, L.3
Mallardi, F.4
Grill, V.5
Zweyer, M.6
Baldini, L.7
-
4
-
-
0034210816
-
Anthracyclines and cardiotoxicity
-
Birtle AJ (2000) Anthracyclines and cardiotoxicity. Clin Oncol 12:146
-
(2000)
Clin Oncol
, vol.12
, pp. 146
-
-
Birtle, A.J.1
-
5
-
-
0030921949
-
ICRF-187 as a cardioprotectant in children treated with anthracyclines
-
Blatt J (1997) ICRF-187 as a cardioprotectant in children treated with anthracyclines. Pediatr Hematol Oncol 14:iii
-
(1997)
Pediatr Hematol Oncol
, vol.14
-
-
Blatt, J.1
-
6
-
-
0032211417
-
Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP
-
Cole SP, Deeley RG (1998) Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioessays 20:931
-
(1998)
Bioessays
, vol.20
, pp. 931
-
-
Cole, S.P.1
Deeley, R.G.2
-
7
-
-
0028816350
-
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma
-
A Southwest Oncology Group study
-
Dalton WS, Crowley JJ, Salmon SS, Grogan TM, Laufman LR, Weiss GR, Bonnet JD (1995) A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study. Cancer 75:815
-
(1995)
Cancer
, vol.75
, pp. 815
-
-
Dalton, W.S.1
Crowley, J.J.2
Salmon, S.S.3
Grogan, T.M.4
Laufman, L.R.5
Weiss, G.R.6
Bonnet, J.D.7
-
8
-
-
0030972084
-
Adriamycin-induced histamine release from heart tissue in vitro
-
Decorti G, Candussio L, Klugmann FB, Strohmayer A, Mucci MP, Mosco A, Baldini L (1997) Adriamycin-induced histamine release from heart tissue in vitro. Cancer Chemother Pharmacol 40:363
-
(1997)
Cancer Chemother Pharmacol
, vol.40
, pp. 363
-
-
Decorti, G.1
Candussio, L.2
Klugmann, F.B.3
Strohmayer, A.4
Mucci, M.P.5
Mosco, A.6
Baldini, L.7
-
9
-
-
0029784750
-
Cytoprotective agents for anthracyclines
-
Dorr RT (1996) Cytoprotective agents for anthracyclines. Semin Oncol 23:23
-
(1996)
Semin Oncol
, vol.23
, pp. 23
-
-
Dorr, R.T.1
-
10
-
-
0028935166
-
Modulators of multidrug resistance. Preclinical studies
-
Ford JM (1995) Modulators of multidrug resistance. Preclinical studies. Hematol Oncol Clin North Am 9:337
-
(1995)
Hematol Oncol Clin North Am
, vol.9
, pp. 337
-
-
Ford, J.M.1
-
11
-
-
0027940433
-
Non-specific effects of calcium entry antagonists in mast cells
-
Franzius D, Hoth M, Penner R (1994) Non-specific effects of calcium entry antagonists in mast cells. Pflugers Arch 428:433
-
(1994)
Pflugers Arch
, vol.428
, pp. 433
-
-
Franzius, D.1
Hoth, M.2
Penner, R.3
-
12
-
-
0033006172
-
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
-
Gewirtz DA (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57:727
-
(1999)
Biochem Pharmacol
, vol.57
, pp. 727
-
-
Gewirtz, D.A.1
-
13
-
-
0030666026
-
A dose-finding and pharmacokinetic study of reversal of multidrug resistance with SDZ PSC 833 in combination with doxorubicin in patients with solid tumors
-
Giaccone G, Linn SC, Welink J, Catimel G, Stieltjes H, van der Vijgh WJ, Eeltink C, Vermorken JB, Pinedo HM (1997) A dose-finding and pharmacokinetic study of reversal of multidrug resistance with SDZ PSC 833 in combination with doxorubicin in patients with solid tumors. Clin Cancer Res 3:2005
-
(1997)
Clin Cancer Res
, vol.3
, pp. 2005
-
-
Giaccone, G.1
Linn, S.C.2
Welink, J.3
Catimel, G.4
Stieltjes, H.5
Van Der Vijgh, W.J.6
Eeltink, C.7
Vermorken, J.B.8
Pinedo, H.M.9
-
14
-
-
0032520979
-
Protection from apoptosis by steel factor but not interleukin-3 is reversed through blockade of calcium influx
-
Gommerman JL, Berger SA (1998) Protection from apoptosis by steel factor but not interleukin-3 is reversed through blockade of calcium influx. Blood 91:1891
-
(1998)
Blood
, vol.91
, pp. 1891
-
-
Gommerman, J.L.1
Berger, S.A.2
-
15
-
-
0027218689
-
Biochemistry of multidrug resistance mediated by the multidrug transporter
-
Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385
-
(1993)
Annu Rev Biochem
, vol.62
, pp. 385
-
-
Gottesman, M.M.1
Pastan, I.2
-
16
-
-
0033813886
-
Molecular basis of anthracycline-induced cardiotoxicity and its prevention
-
Horenstein MS, Vander Heide RS, L'Ecuyer TJ (2000) Molecular basis of anthracycline-induced cardiotoxicity and its prevention. Mol Genet Metab 71:436
-
(2000)
Mol Genet Metab
, vol.71
, pp. 436
-
-
Horenstein, M.S.1
Vander Heide, R.S.2
L'Ecuyer, T.J.3
-
17
-
-
0031837125
-
Chemotherapy resistance in breast cancer
-
Lehnert M (1998) Chemotherapy resistance in breast cancer. Anticancer Res 18:2225
-
(1998)
Anticancer Res
, vol.18
, pp. 2225
-
-
Lehnert, M.1
-
18
-
-
0030738677
-
Multidrug resistance: Molecular mechanisms and clinical relevance
-
Ling V (1997) Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 40:S3
-
(1997)
Cancer Chemother Pharmacol
, vol.40
-
-
Ling, V.1
-
19
-
-
0027455027
-
Randomized phase II study of single-agent epirubicin ± verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial
-
Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society
-
Mross K, Bohn C, Edler L, Jonat W, Queisser W, Heidemann E, Goebel M, Hossfeld DK (1993) Randomized phase II study of single-agent epirubicin ± verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society. Ann Oncol 4:45
-
(1993)
Ann Oncol
, vol.4
, pp. 45
-
-
Mross, K.1
Bohn, C.2
Edler, L.3
Jonat, W.4
Queisser, W.5
Heidemann, E.6
Goebel, M.7
Hossfeld, D.K.8
-
20
-
-
0033518874
-
Atypical multidrug resistance: Breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines
-
Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, Lage H, Dietel M, Greenberger L, Cole SP, Doyle LA (1999) Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst 91:429
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 429
-
-
Ross, D.D.1
Yang, W.2
Abruzzo, L.V.3
Dalton, W.S.4
Schneider, E.5
Lage, H.6
Dietel, M.7
Greenberger, L.8
Cole, S.P.9
Doyle, L.A.10
-
21
-
-
0027466646
-
Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance
-
Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, van Heijningen TH, van Kalken CK, Slovak ML, de Vries EG, van der Valk P, et al (1993) Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 53:1475
-
(1993)
Cancer Res
, vol.53
, pp. 1475
-
-
Scheper, R.J.1
Broxterman, H.J.2
Scheffer, G.L.3
Kaaijk, P.4
Dalton, W.S.5
Van Heijningen, T.H.6
Van Kalken, C.K.7
Slovak, M.L.8
De Vries, E.G.9
Van Der Valk, P.10
-
22
-
-
0028009810
-
Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance
-
Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH (1994) Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res 54:152
-
(1994)
Cancer Res
, vol.54
, pp. 152
-
-
Schneider, E.1
Horton, J.K.2
Yang, C.H.3
Nakagawa, M.4
Cowan, K.H.5
-
23
-
-
0030738096
-
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
-
Sikic BI, Fisher GA, Lum BL, Halsey J, Beketic-Oreskovic L, Chen G (1997) Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother Pharmacol 40:S13
-
(1997)
Cancer Chemother Pharmacol
, vol.40
-
-
Sikic, B.I.1
Fisher, G.A.2
Lum, B.L.3
Halsey, J.4
Beketic-Oreskovic, L.5
Chen, G.6
-
24
-
-
0037133929
-
2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells
-
2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. J Biol Chem 277:13812
-
(2002)
J Biol Chem
, vol.277
, pp. 13812
-
-
Soboloff, J.1
Berger, S.A.2
-
25
-
-
0036791037
-
Sensitivity of myeloid leukemia cells to calcium influx blockade: Application to bone marrow purging
-
Soboloff J, Zhang Y, Minden M, Berger SA (2002) Sensitivity of myeloid leukemia cells to calcium influx blockade: application to bone marrow purging. Exp Hematol 30:1219
-
(2002)
Exp Hematol
, vol.30
, pp. 1219
-
-
Soboloff, J.1
Zhang, Y.2
Minden, M.3
Berger, S.A.4
-
26
-
-
0005468060
-
Valspodar + paclitaxel in advanced breast cancer: A California Cancer Consortium phase II randomized trial
-
abstract 696
-
Spicer D, Arzoo K, Groshen S, et al (2000) Valspodar + paclitaxel in advanced breast cancer: a California Cancer Consortium phase II randomized trial (abstract 696). Proc ASCO 19:179a
-
(2000)
Proc ASCO
, vol.19
-
-
Spicer, D.1
Arzoo, K.2
Groshen, S.3
-
27
-
-
0026480458
-
Effects of verapamil on the acute toxicity of doxorubicin in vivo
-
Sridhar R, Dwivedi C, Anderson J, Baker PB, Sharma HM, Desai P, Engineer FN (1992) Effects of verapamil on the acute toxicity of doxorubicin in vivo. J Natl Cancer Inst 84:1653
-
(1992)
J Natl Cancer Inst
, vol.84
, pp. 1653
-
-
Sridhar, R.1
Dwivedi, C.2
Anderson, J.3
Baker, P.B.4
Sharma, H.M.5
Desai, P.6
Engineer, F.N.7
-
29
-
-
0030920342
-
Multidrug resistance in breast cancer: A meta-analysis of MDR1/gp170 expression and its possible functional significance
-
Trock BJ, Leonessa F, Clarke R (1997) Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance. J Natl Cancer Inst 89:917
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 917
-
-
Trock, B.J.1
Leonessa, F.2
Clarke, R.3
-
30
-
-
0008632564
-
Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine
-
Ueda K, Cardarelli C, Gottesman MM, Pastan I (1987) Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci U S A 84:3004
-
(1987)
Proc Natl Acad Sci U S A
, vol.84
, pp. 3004
-
-
Ueda, K.1
Cardarelli, C.2
Gottesman, M.M.3
Pastan, I.4
-
31
-
-
0036010918
-
Purging of contaminating breast cancer cells from hematopoietic progenitor cell preparations using activation enhanced cell death
-
Zhang Y, Crump M, Berger SA (2002) Purging of contaminating breast cancer cells from hematopoietic progenitor cell preparations using activation enhanced cell death. Breast Cancer Res Treat 72:265
-
(2002)
Breast Cancer Res Treat
, vol.72
, pp. 265
-
-
Zhang, Y.1
Crump, M.2
Berger, S.A.3
|